Clinical Trials Directory

Trials / Completed

CompletedNCT00885300

Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Shiraz University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate whether cloxacillin lock is effective in prevention of double lumen infection.

Detailed description

Double lumen infection is one of the causes of morbidity and mortality in hemodialysis patients. Many strategies used to prevent it and one of them is antibiotic lock. Thus we select chronic hemodialysis patients and divided them into 2 groups. One group received cloxacillin and heparin as catheter lock and the second group received only heparin lock.

Conditions

Interventions

TypeNameDescription
DRUGcloxacillincloxacillin 100mg/ml as catheter lock at the end of hemodialysis
DRUGheparinheparin 1000iu/ml as catheter lock at the end of hemodialysis

Timeline

Start date
2008-01-01
Primary completion
2008-07-01
Completion
2008-09-01
First posted
2009-04-21
Last updated
2009-04-21

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00885300. Inclusion in this directory is not an endorsement.